Literature DB >> 11507721

Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.

N Chatterjee1, J Shih, P Hartge, L Brody, M Tucker, S Wacholder.   

Abstract

When a rare inherited mutation in a disease gene, such as BRCA1, is found through extensive study of high-risk families, it is critical to estimate not only age-specific penetrance of the disease associated with the mutation, but also the residual effect of family history once the mutation is taken into account. The kin-cohort design, a cross-sectional survey of a suitable population that collects DNA and family history data, provides an efficient alternative to cohort or case-control designs for estimating age-specific penetrance in a population not selected because of high familial risk. In this report, we develop a method for analyzing kin-cohort data that simultaneously estimate the age-specific cumulative risk of the disease among the carriers and non-carriers of the mutations and the gene-adjusted residual familial aggregation or correlation of the disease. We employ a semiparametric modeling approach, where the marginal cumulative risks corresponding to the carriers and non-carriers are treated non-parametrically and the residual familial aggregation is described parametrically by a class of bivariate failure time models known as copula models. A simple and robust two-stage method is developed for estimation. We apply the method to data from the Washington Ashkenazi Study [Struewing et al., 1997, N Engl J Med 336:1401-1408] to study the residual effect of family history on the risk of breast cancer among non-carriers and carriers of specific BRCA1/BRCA2 germline mutations. We find that positive history of a single first-degree relative significantly increases risk of the non-carriers (RR = 2.0, 95% CI = 1.6-2.6) but has little or no effect on the carriers. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507721     DOI: 10.1002/gepi.1022

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  3 in total

Review 1.  Hereditary breast cancer in Jews.

Authors:  Wendy S Rubinstein
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

2.  Estimation of genotype relative risks from pedigree data by retrospective likelihoods.

Authors:  Daniel J Schaid; Shannon K McDonnell; Shaun M Riska; Erin E Carlson; Stephen N Thibodeau
Journal:  Genet Epidemiol       Date:  2010-05       Impact factor: 2.135

3.  Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.

Authors:  Ranjit Manchanda; Kelly Loggenberg; Saskia Sanderson; Matthew Burnell; Jane Wardle; Sue Gessler; Lucy Side; Nyala Balogun; Rakshit Desai; Ajith Kumar; Huw Dorkins; Yvonne Wallis; Cyril Chapman; Rohan Taylor; Chris Jacobs; Ian Tomlinson; Alistair McGuire; Uziel Beller; Usha Menon; Ian Jacobs
Journal:  J Natl Cancer Inst       Date:  2014-11-30       Impact factor: 13.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.